Literature DB >> 1882894

Treatment of peptic ulcer disease with sucralfate: a review.

R H Hunt1.   

Abstract

Sucralfate has been used widely for the treatment of peptic ulcer. Healing rates for duodenal ulcer range from 60 to 90% at 4-6 weeks and up to 90% at 12 weeks for gastric ulcer. The small number of maintenance trials suggest that relapse of duodenal ulcer is reduced comparably to H2 receptor antagonists. There has been considerable interest in the possibility of lower relapse ratios after initial healing with sucralfate compared with H2 receptor antagonists, but more studies of the possible mechanisms as well as larger trials are still needed to confirm these observations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1882894     DOI: 10.1016/0002-9343(91)90459-b

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  2 in total

1.  Effect of long-term sucralfate ingestion on antral and fundic epithelial proliferation in the rat.

Authors:  H Kuwayama
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

Review 2.  Pharmacological aspects of acid secretion.

Authors:  B I Hirschowitz; D Keeling; M Lewin; S Okabe; M Parsons; K Sewing; B Wallmark; G Sachs
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.